63
Views
10
CrossRef citations to date
0
Altmetric
Review

Interventions targeting the prescribing and monitoring of vancomycin for hospitalized patients: a systematic review with meta-analysis

, , , &
Pages 2081-2094 | Published online: 31 Oct 2018

References

  • Moellering RC. Vancomycin: a 50-year reassessment. Clin Infect Dis. 2006;42(Suppl 1):S3–S4.
  • Rybak MJ. The pharmacokinetic and pharmacodynamic properties of vancomycin. Clin Infect Dis. 2006;42(Suppl 1):S35–S39.
  • Giuliano C, Giulano C, Haase KK, Hall R. Use of vancomycin pharmacokinetic-pharmacodynamic properties in the treatment of MRSA infections. Expert Rev Anti Infect Ther. 2010;8(1):95–106.
  • Ye ZK, Tang HL, Zhai SD. Benefits of therapeutic drug monitoring of vancomycin: a systematic review and meta-analysis. PLoS One. 2013;8(10):e77169.
  • Howden BP, Davies JK, Johnson PD, Stinear TP, Grayson ML. Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications. Clin Microbiol Rev. 2010;23(1):99–139.
  • Avent ML, Vaska VL, Rogers BA, et al. Vancomycin therapeutics and monitoring: a contemporary approach. Intern Med J. 2013;43(2):110–119.
  • O’Neill J [homepage on the Internet]. Review on Antimicrobial Resistance: Tackling Drug-Resistant Infections Globally. London, England; 2016. Available from https://amr-review.org/. Accessed June 5, 2018.
  • Rybak M, Lomaestro B, Rotschafer JC, et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm. 2009;66(1):82–98.
  • Matsumoto K, Takesue Y, Ohmagari N, et al. Practice guidelines for therapeutic drug monitoring of vancomycin: a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring. J Infect Chemother. 2013;19(3):365–380.
  • Ye ZK, Chen YL, Chen K, et al. Therapeutic drug monitoring of vancomycin: a guideline of the Division of Therapeutic Drug Monitoring, Chinese Pharmacological Society. J Antimicrob Chemother. 2016;71(11):3020–3025.
  • Ye ZK, Li C, Zhai SD. Guidelines for therapeutic drug monitoring of vancomycin: a systematic review. PLoS One. 2014;9(6):e99044.
  • Qaseem A, Forland F, Macbeth F, et al. Guidelines International Network: toward international standards for clinical practice guidelines. Ann Intern Med. 2012;156(7):525–531.
  • Steinbrook R. Improving clinical practice guidelines. JAMA Intern Med. 2014;174(2):181.
  • Ye ZK, Chen K, Chen YL, Zhai SD. A protocol for developing a clinical practice guideline for therapeutic drug monitoring of vancomycin. J Huazhong Univ Sci Technolog Med Sci. 2016;36(3):469–472.
  • Cabana MD, Rand CS, Powe NR, et al. Why don’t physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999;282(15):1458–1465.
  • Lomas J, Anderson GM, Domnick-Pierre K, Vayda E, Enkin MW, Hannah WJ. Do practice guidelines guide practice? The effect of a consensus statement on the practice of physicians. N Engl J Med. 1989;321(19):1306–1311.
  • Chen CL, Lin GA, Bardach NS, et al. Preoperative medical testing in Medicare patients undergoing cataract surgery. N Engl J Med. 2015;372(16):1530–1538.
  • Mol PG, Rutten WJ, Gans RO, Degener JE, Haaijer-Ruskamp FM. Adherence barriers to antimicrobial treatment guidelines in teaching hospital, the Netherlands. Emerg Infect Dis. 2004;10(3):522–525.
  • National Institute for Health and Clinical Excellence (NICE) [homepage on the Internet]. PMG20 Developing Nice guidelines: the manual. London, UK: National Institute for Health and Clinical Excellence; 2017. Available from: https://www.nice.org.uk/process/pmg20/resources/developing-nice-guidelines-the-manual-pdf-72286708700869. Accessed October 3, 2018.
  • Graham R, Mancher M, Wolman DM, Greenfield S, Steinberg E. Clinical practice guidelines we can trust. Washington, DC: National Academies Press. 2011.
  • National Health and Medical Research Council. Procedures and requirements for meeting the 2011 NHMRC standard for clinical practice guideline; 2011. Melbourne: National Health and Medical Research Council.
  • Forsetlund L, Bjørndal A, Rashidian A, et al. Continuing education meetings and workshops: effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2009 (2):CD003030.
  • National Health and Medical Research Council (NHMRC). A guide to the development, implemenation and evaluation of clinical practice guidelines. Canberra: National Health and Medical Research Council; 1999.
  • Giguère A, Légaré F, Grimshaw J, et al. Printed educational materials: effects on professional practice and healthcare outcomes. Cochrane Database Syst Rev. 2012;10:CD004398.
  • Phillips CJ, Wisdom AJ, McKinnon RA, Woodman RJ, Gordon DL. Interventions targeting the prescribing and monitoring of vancomycin for hospitalized patients: A systematic review protocol. Infect Dis Ther. 2017;6(4):557–563.
  • Shamseer L, Moher D, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;350:g7647.
  • Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1.
  • Scottish Intercollegial Guideline Network. SIGN 50. A Guideline Developers’ Handbook; 2015. Available from: http://www.sign.ac.uk/sign-50.html. Accessed Accessed 5 June 2018.
  • Kim S, Yeganova L, Wilbur WJ. Meshable: searching PubMed abstracts by utilizing MeSH and MeSH-derived topical terms. Bioinformatics. 2016;32(19):3044–3046.
  • Bosso JA, Nappi J, Rudisill C, et al. Relationship between vancomycin trough concentrations and nephrotoxicity: a prospective multicenter trial. Antimicrob Agents Chemother. 2011;55(12):5475–5479.
  • Rybak MJ, Lomaestro BM, Rotschafer JC, et al. Therapeutic monitoring of vancomycin in adults summary of consensus recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Pharmacother. 2009;29:1275–1279.
  • Effective Practice and Organisation of Care (EPOC) [webpage on the Internet]. EPOC Taxonomy; 2015. Available from: https://epoc.cochrane.org/epoc-taxonomy. Accessed 5 June 2018.
  • Sterne JA, Hernán MA, Reeves BC, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919.
  • Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–560.
  • Hammond DA, Atkinson LN, James TB, Painter JT, Lusardi K. Effects of staff education and standardizing dosing and collection times on vancomycin trough appropriateness in ward patients. Pharm Pract. 2017;15(2):949.
  • O’Brien KA, Mok S. Evaluation of the safety of a vancomycin nomogram used to achieve target trough concentrations. Hosp Pharm. 2015;50(10):900–910.
  • Phillips CJ, Mckinnon RA, Woodman RJ, Gordon DL. Sustained improvement in vancomycin dosing and monitoring post-implementation of guidelines: Results of a three-year follow-up after a multifaceted intervention in an Australian teaching hospital. J Infect Chemother. 2018;24(2):103–109.
  • Swartling M, Gupta R, Dudas V, Guglielmo BJ. Short term impact of guidelines on vancomycin dosing and therapeutic drug monitoring. Int J Clin Pharm. 2012;34(2):282–285.
  • Coleman LK, Wilson AS. Impact of nursing education on the proportion of appropriately drawn vancomycin trough concentrations. J Pharm Pract. 2016;29(5):472–474.
  • Carroll DJ, Austin GE, Stajich GV, Miyahara RK, Murphy JE, Ward ES. Effect of education on the appropriateness of serum drug concentration determination. Ther Drug Monit. 1992;14(1):81–84.
  • Grudniewicz A, Kealy R, Rodseth RN, Hamid J, Rudoler D, Straus SE. What is the effectiveness of printed educational materials on primary care physician knowledge, behaviour, and patient outcomes: a systematic review and meta-analyses. Implement Sci. 2015;10:164.
  • Squires JE, Sullivan K, Eccles MP, Worswick J, Grimshaw JM. Are multifaceted interventions more effective than single-component interventions in changing health care professionals’ behaviours? An overview of systematic reviews. Implement Sci. 2014;9:152.
  • Kovacs E, Strobl R, Phillips A, et al. Systematic review and meta-analysis of the effectiveness of implementation strategies for non-communicable disease guidelines in primary health care. J Gen Intern Med. 2018;33(7):1142–1154.
  • Phillips JC, McKinnon AR, Woodman JR, Gordon LD. Junior doctors’ preparedness to prescribe, monitor, and treat patients with the antibiotic vancomycin in an Australian teaching hospital. J Educ Eval Health Prof. 2017;14:13.
  • Grimshaw JM, Thomas RE, MacLennan G, et al. Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess. 2004;8(6):1–72.
  • Grol R, Grimshaw J. From best evidence to best practice: effective implementation of change in patients’ care. Lancet. 2003;362(9391):1225–1230.
  • Phillips CJ, Marshall AP, Chaves NJ, et al. Experiences of using the Theoretical Domains Framework across diverse clinical environments: a qualitative study. J Multidiscip Healthc. 2015;8:139–146.
  • Michie S, Johnston M, Abraham C, et al. Making psychological theory useful for implementing evidence based practice: a consensus approach. Qual Saf Health Care. 2005;14(1):26–33.
  • Michie S, Carey RN, Johnston M, et al. From theory-inspired to theory-based interventions: A protocol for developing and testing a methodology for linking behaviour change techniques to theoretical mechanisms of action. Ann Behav Med. 2016;52:501–512.
  • Grayson ML, Macesic N, Huang GK, et al. Use of an innovative personality-mindset profiling tool to guide culture-change strategies among different healthcare worker groups. PLoS One. 2015;10(10):e0140509.
  • Davey P, Peden C, Charani E, Marwick C, Michie S. Time for action-Improving the design and reporting of behaviour change interventions for antimicrobial stewardship in hospitals: Early findings from a systematic review. Int J Antimicrob Agents. 2015;45(3):203–212.
  • Moxey A, Robertson J, Newby D, Hains I, Williamson M, Pearson SA. Computerized clinical decision support for prescribing: provision does not guarantee uptake. J Am Med Inform Assoc. 2010;17(1):25–33.
  • Gillaizeau F, Chan E, Trinquart L, et al. Computerized advice on drug dosage to improve prescribing practice. Cochrane Database Syst Rev. 2013 (11):CD002894. doi: cd002894.
  • Mccluggage L, Lee K, Potter T, Dugger R, Pakyz A. Implementation and evaluation of vancomycin nomogram guidelines in a computerized prescriber-order-entry system. Am J Health Syst Pharm. 2010;67(1):70–75.
  • Burdette SD, Trotman R, Cmar J. Mobile infectious disease references: from the bedside to the beach. Clin Infect Dis. 2012;55(1):114–125.
  • Riley RD, Higgins JP, Deeks JJ. Interpretation of random effects meta-analyses. BMJ. 2011;342:d549.